Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>The medical technology group focused on the durable healing of wounds and the prevention of amputations, today announces that topical oxygen therapy is included in the National Institute for Health and Care Excellence updated Diabetic Foot Problems: Prevention and Management guideline, and the Company's Topical Wound Oxygen therapy is now active on the Advanced Wound Care framework, awarded by NHS Supply Chain.</li>
<li>The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to treatment, reflecting increasing recognition from national health authorities of the clinical value and potential of TWO2 therapy to improve outcomes in difficult-to-heal wounds.</li>
</ul>


The medical technology group focused on the durable healing of wounds and the prevention of amputations, today announces that topical oxygen therapy is included in the National Institute for Health and Care Excellence updated Diabetic Foot Problems: Prevention and Management guideline, and the Company's Topical Wound Oxygen therapy is now active on the Advanced Wound Care framework, awarded by NHS Supply Chain.
The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to treatment, reflecting increasing recognition from national health authorities of the clinical value and potential of TWO2 therapy to improve outcomes in difficult-to-heal wounds.


Videndum Plc - Hybridan Small Cap Feast: 03/09/2025

US-EU Index Rebalances / Quantitative Researcher, ORTEX

Dimitris Ioannidis

US-EU Index Rebalances / Quantitative Researcher

Global Financial Data and Analytics Platform

ORTEX

ORTEX is a global financial data and analytics platform providing real-time securities lending and short interest data, index rebalance data, holdings and insider transactions, trading signals, corporate actions and news,  stock machine learning and factor scores and other analytics. The majority of the data are downloadable and accessible through APIs.

Index Rebalance

<ul>
<li>
<a href="https://www.smartkarma.com/entities/the-schiehallion-fund-limited" target="_blank" data-smartkarma-citation="entities:46402:1" rel="noopener">Schiehallion Fund (MNTN LN)</a> is the flagship forecasted addition at the March 2026 review following its listing transfer to the LSE Main Market.</li>
<li>
<a href="https://www.smartkarma.com/entities/ashtead-group-plc" target="_blank" data-smartkarma-citation="entities:21806:1" rel="noopener">Ashtead (AHT LN)</a> is expected to experience significant supply from UK index funds in February and demand from US in June following its corporate &amp; listing structure change.</li>
<li>
<a href="https://www.smartkarma.com/entities/tritax-big-box-reit-plc" target="_blank" data-smartkarma-citation="entities:21830:1" rel="noopener">Tritax Big Box Reit (BBOX LN)</a> and <a href="https://www.smartkarma.com/entities/ig-group-holdings-plc" target="_blank" data-smartkarma-citation="entities:21989:1" rel="noopener">Ig Group Holdings (IGG LN)</a> are the main candidates to replace <a href="https://www.smartkarma.com/entities/ashtead-group-plc" target="_blank" data-smartkarma-citation="entities:21806:1" rel="noopener">Ashtead (AHT LN)</a> and be added to F100 at the review.</li>
</ul>



Schiehallion Fund (MNTN LN) is the flagship forecasted addition at the March 2026 review following its listing transfer to the LSE Main Market.

Ashtead (AHT LN) is expected to experience significant supply from UK index funds in February and demand from US in June following its corporate &amp; listing structure change.

Tritax Big Box Reit (BBOX LN) and Ig Group Holdings (IGG LN) are the main candidates to replace Ashtead (AHT LN) and be added to F100 at the review.


UK Index Forecasts - Mar26: Schiehallion Fund Headlines F250; Ashtead Moves to US

Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

Pan-Asia Catalysts/Events

Quiddity Advisors

Empiric Student Property / Index Rebalance

<ul>
<li>In this insight, we take a look at Quiddity's final predictions for index changes for the  F100 and F250 indices for the June 2023 Rebalance.</li>
<li>The index changes are likely to be confirmed after market close today.</li>
<li>We expect one change for the F100 index and six changes for the F250 index.</li>
</ul>


In this insight, we take a look at Quiddity's final predictions for index changes for the  F100 and F250 indices for the June 2023 Rebalance.
The index changes are likely to be confirmed after market close today.
We expect one change for the F100 index and six changes for the F250 index.


Quiddity Final Thoughts for F100/​250 June 23: Multiple High-Impact Changes Likely

United Kingdom

Videndum PLC designs, manufactures and distributes camera supports, camera mounted electronic accessories, robotic camera systems, prompters, LED lights, mobile power, monitors, bags, motion control, smart phone accessories, audio capture, and noise reduction equipment.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Videndum (VID LN)

Videndum Plc - Hybridan Small Cap Feast: 03/09/2025

The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to...

Hybridan

UK Index Forecasts - Mar26: Schiehallion Fund Headlines F250; Ashtead Moves to US

AHT was removed from F100 and saw passive fund supply of ~29m shares, $2bn, 16 ADV at the close on 27 February. BBOX replaced AHT in F100, and COST...

Dimitris Ioannidis

Quiddity Final Thoughts for F100/250 June 23: Multiple High-Impact Changes Likely

The F100 and F250 data cutoff has passed. The announcement of changes should come today after the London close. We see multiple high-impact...

Travis Lundy

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Videndum Plc - Hybridan Small Cap Feast: 03/09/2025

The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to...

Hybridan

UK Index Forecasts - Mar26: Schiehallion Fund Headlines F250; Ashtead Moves to US

AHT was removed from F100 and saw passive fund supply of ~29m shares, $2bn, 16 ADV at the close on 27 February. BBOX replaced AHT in F100, and COST...

Dimitris Ioannidis

Quiddity Final Thoughts for F100/​250 June 23: Multiple High-Impact Changes Likely

The F100 and F250 data cutoff has passed. The announcement of changes should come today after the London close. We see multiple high-impact...

Travis Lundy

Quiddity Final Thoughts for F100/250 June 23: Multiple High-Impact Changes Likely